Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 5, 2021
Patent Application Number
15987933
Date Filed
May 24, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are compositions for reducing symptoms of post-traumatic stress disorder. The compositions include a combination of an N-methyl-D-aspartate (NMDA) receptor antagonist and an anti-depression agent.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.